Search

Your search keyword '"Yamamoto, Haruko"' showing total 346 results

Search Constraints

Start Over You searched for: Author "Yamamoto, Haruko" Remove constraint Author: "Yamamoto, Haruko"
346 results on '"Yamamoto, Haruko"'

Search Results

2. Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial

4. Optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis: study protocol for a randomized controlled trial.

7. Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention

9. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

10. Abstract WMP2: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial in Acute Non-Cardioembolic Ischemic Stroke With Adrenomedullin

16. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data

17. Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy

18. Cigarette Smoking as a Risk Factor for Hematoma Expansion in Primary Intracerebral Hemorrhage: Analysis From a Randomized Clinical Trial

21. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial

25. P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study

26. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study

27. Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial

29. Blood Pressure-Attained Analysis of ATACH 2 Trial

32. Disease duration: the key to accurate CSF tap test in iNPH

33. Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)

35. sj-pdf-1-wso-10.1177_17474930211044635 - Supplemental material for Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review

37. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol

38. Effect of Eicosapentaenoic Acid/ Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Non-Contrast T1-Weighted Imaging: A Randomized Trial

41. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation

44. Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial

45. sj-pdf-1-wso-10.1177_17474930211035023 - Supplemental material for Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial

48. Cerebral microbleeds development after stroke thrombolysis: A secondary analysis of the THAWS randomized clinical trial.

49. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.

Catalog

Books, media, physical & digital resources